Coupled transcriptome and proteome analysis of human lymphotropic tumor viruses: Insights on the detection and discovery of viral genes

BMC Genomics

Volumn 12, Issue , 2011, Pages

  Dresang, Lindsay R ^a,b   Teuton, Jeremy R ^c   Feng, Huichen ^a   Jacobs, Jon M ^c   Camp II, David G ^c   Purvine, Samuel O ^c   Gritsenko, Marina A ^c   Li, Zhihua ^a   Smith, Richard D ^c   Sugden, Bill ^b   Moore, Patrick S ^a   Chang, Yuan ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEOME; TRANSCRIPTOME; VIRUS PROTEIN;

ARTICLE; BURKITT LYMPHOMA; COMPLEMENT SYSTEM; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE EXPRESSION; GENE IDENTIFICATION; GENE SEQUENCE; HUMAN HERPESVIRUS 8; LIFE CYCLE STAGE; LIQUID CHROMATOGRAPHY; LYMPHOMA CELL LINE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIMARY EFFUSION LYMPHOMA; PROTEIN EXPRESSION; PROTEOMICS; TANDEM MASS SPECTROMETRY; VIRUS DETECTION; VIRUS GENE; VIRUS GENOME; VIRUS TRANSCRIPTION; GENETICS; HUMAN; MASS SPECTROMETRY; METABOLISM;

HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 8;

GENES, VIRAL; HERPESVIRUS 4, HUMAN; HERPESVIRUS 8, HUMAN; HUMANS; MASS SPECTROMETRY; PROTEOME; TRANSCRIPTOME;

EID: 83655183273     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-12-625     Document Type: Article

References (71)

1. Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1964, 283(7335):702-703.
2. Lindahl T, Klein G, Reedman BM, Johansson B, Singh S. Relationship between Epstein-Barr virus (EBV) DNA and the EBV-determined nuclear antigen (EBNA) in Burkitt lymphoma biopsies and other lymphoproliferative malignancies. Int J Cancer 1974, 13(6):764-772.
3. Nonoyama M, Huang CH, Pagano JS, Klein G, Singh S. DNA of Epstein-Barr virus detected in tissue of Burkitt's lymphoma and nasopharyngeal carcinoma. Proc Natl Acad Sci USA 1973, 70(11):3265-3268.
4. zur Hausen H, Schulte-Holthausen H, Klein G, Henle W, Henle G, Clifford P, Santesson L. EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature 1970, 228(5276):1056-1058.
5. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994, 266:1865-1869.
6. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 1995, 332(18):1186-1191.
7. Uphoff CC, Habig S, Carbone A, Gaidano G, Drexler HG. HHV-8 infection is specific for cell lines derived from primary effusion (body cavity-based) lymphomas. Leukemia 1998, 12(11):1806-9.
8. Chen YB, Rahemtullah A, Hochberg E. Primary effusion lymphoma. Oncologist 2007, 12:569-576.
9. Moore PS, Chang Y. Molecular virology of Kaposi's sarcoma-associated herpesvirus. Philos Trans R Soc Lond B Biol Sci 2001, 356(1408):499-516.
10. Moore PS, Chang Y. Kaposi's sarcoma-associated herpesvirus immunoevasion and tumorigenesis: two sides of the same coin?. Annu Rev Microbiol 2003, 57:609-639.
11. Vereide D, Sugden B. Proof for EBV's sustaining role in Burkitt's lymphomas. Semin Cancer Biol 2009, 19(6):389-393.
12. Baer R, Bankier AT, Biggin MD, Deininger PL, Farrell PJ, Gibson TJ, Hatfull G, Hudson GS, Satchwell SC, Séguin C, Tuffnell PS, Barrell BG. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 1984, 310(5974):207-211.
13. Russo JJ, Bohenzky RA, Chien MC, Chen J, Yan M, Maddalena D, Parry JP, Peruzzi D, Edelman IS, Chang Y, Moore PS. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci USA 1996, 93:14862-14867.
14. Lerner MR, Andrews NC, Miller G, Steitz JA. Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematous. Proc Natl Acad Sci USA 1981, 78(2):805-809.
15. Sun R, Lin SF, Gradoville L, Miller G. Polyadenylated nuclear RNA encoded by Kaposi sarcoma-associated herpesvirus. Proc Natl Acad Sci USA 1996, 93:11883-11888.
16. Li H, Komatsu T, Dezube BJ, Kaye KM. The Kaposi's sarcoma-associated herpesvirus K12 transcript from a primary effusion lymphoma contains complex repeat elements, is spliced, and initiates from a novel promoter. J Virol 2002, 76(23):11880-11888.
17. Sadler R, Wu L, Forghani B, Renne R, Zhong W, Herndier B, Ganem D. A complex translational program generates multiple novel proteins from the latently expressed kaposin (K12) locus of Kaposi's sarcoma-associated herpesvirus. J Virol 1999, 73(7):5722-5730.
18. Xu Y, Ganem D. Making sense of antisense: seemingly noncoding RNAs antisense to the master regulator of Kaposi's sarcoma-associated herpesvirus lytic replication do not regulate that transcript but serve as mRNAs encoding small peptides. J Virol 2010, 84(11):5465-5475.
19. Fischer D, Robert MF, Shedd D, Summers WP, Robinson JE, Wolak J, Stefano JE, Miller G. Identification of Epstein-Barr nuclear antigen polypeptide in mouse and monkey cells after gene transfer with a cloned 2.9-kilobase-pair subfragment of the genome. Proc Natl Acad Sci USA 1984, 81:43-47.
20. Hennessey K, Kieff E. One of two Epstein-Barr virus nuclear antigens contains a glycine-alanine copolymer domain. Proc Natl Acad Sci USA 1983, 80:5665-5669.
21. Rainbow L, Platt GM, Simpson GR, Sarid R, Gao SJ, Stoiber H, Herrington CS, Moore PS, Schulz TF. The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen. J Virol 1997, 71(8):5915-5921.
22. Ossevoort M, Zaldumbide A, te Velthuis AJ, Melchers M, Ressing ME, Wiertz EJ, Hoeben RC. The nested open reading frame in the Epstein-Barr virus nuclear antigen-1 mRNA encodes a protein capable of inhibiting antigen presentation in cis. Mol Immunol 2007, 44(14):3588-3596.
23. Sarid R, Flore O, Bohenzky RA, Chang Y, Moore PS. Transcription mapping of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1). J Virol 1998, 72(2):1005-1012.
24. Spadavecchia S, Gonzalez-Lopez O, Carroll KD, Palmeri D, Lukac DM. Convergence of Kaposi's sarcoma-associated herpesvirus reactivation with Epstein-Barr virus latency and cellular growth mediated by the notch signaling pathway in coinfected cells. J Virol 2010, 84(20):10488-10500.
25. Johannsen E, Luftig M, Chase MR, Weicksel S, Cahir-McFarland E, Illanes D, Sarracino D, Kieff E. Proteins of purified Epstein-Barr virus. Proc Natl Acad Sci USA 2004, 101(46):16286-16291.
26. Taylor JL, Bennett HN, Snyder BA, Moore PS, Chang Y. Transcriptional analysis of latent and inducible Kaposi's sarcoma-associated herpesvirus transcripts in the K4 to K7 region. J Virol 2005, 79(24):15099-15106.
27. Chandriani S, Ganem D. Array-based transcript profiling and limiting-dilution reverse transcription-PCR analysis identify additional latent genes in Kaposi's sarcoma-associated herpesvirus. J Virol 2010, 84(11):5565-5573.
28. Chandriani S, Xu Y, Ganem D. The lytic transcriptome of Kaposi's sarcoma-associated herpesvirus reveals extensive transcription of noncoding regions, including regions antisense to important genes. J Virol 2010, 84(16):7934-7942.
29. Rowe M, Kelly GL, Bell AI, Rickinson AB. Burkitt's lymphoma: The Rosetta Stone deciphering Epstein-Barr virus biology. Semin Cancer Biol 2009, 19(6):377-388.
30. Gregory CD, Rowe M, Rickinson AB. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line. J Gen Virol 1990, 71(Pt7):1481-1495.
31. Horenstein MG, Nador RG, Chadburn A, Hyjek EM, Inghirami G, Knowles DM, Cesarman E. Epstein-Barr virus latent gene expression in primary effusion lymphomas containing Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8. Blood 1997, 90(3):1186-1191.
32. Wu TC, Mann RB, Epstein JI, MacMahon E, Lee WA, Charache P, Hayward SD, Kurman RJ, Hayward GS, Ambinder RF. Abundant expression of EBER1 small nuclear RNA in nasopharyngeal carcinoma. A morphologically distinctive target for detection of Epstein-Barr virus in formalin-fixed paraffin-embedded carcinoma specimens. Am J Pathol 1991, 138(6):1461-1469.
33. Cannon JS, Ciufo D, Hawkins AL, Griffin CA, Borowitz MJ, Hayward GS, Ambinder RF. A new primary effusion lymphoma-derived cell line yields a highly infectious Kaposi's sarcoma herpesvirus-containing supernatant. J Virol 2000, 74(21):10187-10193.
34. Miller G, Heston L, Grogan E, Gradoville L, Rigsby M, Sun R, Shedd D, Kushnaryov VM, Grossberg S, Chang Y. Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells. J Virol 1997, 71(1):314-324.
35. Payne SH, Huang ST, Pieper R. A proteogenomic update to Yersinia: enhancing genome annotation. BMC Genomics 2010, 11:460.
36. Feng H, Taylor JL, Benos PV, Newton R, Waddell K, Lucas SB, Chang Y, Moore PS. Human transcriptome subtraction by using short sequence tags to search for tumor viruses in conjunctival carcinoma. J Virol 2007, 81(20):11332-11340.
37. Vivancos AP, Güell M, Dohm JC, Serrano L, Himmelbauer H. Strand-specific deep sequencing of the transcriptome. Genome Res 2010, 20(7):989-999.
38. Jacobs JM, Diamond DL, Chan EY, Gritsenko MA, Qian WJ, Stastna M, Baas T, Camp DG, Carithers RL, Smith RD, Katze MG. Proteome analysis of liver cells expressing a full-length Hepatitis C virus (HCV) replicon and biopsies of post-transplanted liver from HCV-infected patients. J Virol 2005, 12:7558-7569.
39. Gao J, Friedrichs MS, Dongre AR, Opiteck GJ. Guidelines for the routine application of the peptide hits technique. J Am Soc Mass Spectrom 2005, 16(8):1231-1238.
40. Liu H, Sadygov RG, Yates JR. A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal Chem 2004, 76(14):4193-4201.
41. Qian WJ, Jacobs JM, Camp DG, Monroe ME, Moore RJ, Gritsenko MA, Calvano SE, Lowry SF, Xiao W, Moldawer LL, Davis RW, Tompkins RG, Smith RD. Comparative proteome analyses of human plasma following in vivo lipopolysaccharide administration using multidimensional separations coupled tandem mass spectrometry. Proteomics 2005, 5(2):572-584.
42. Rennekamp AJ, Lieberman PM. Initiation of EBV lytic replication requires transcription and the formation of a stable RNA-DNA hybrid molecule at OriLyt. J Virol 2010, 85(6):2837-2850.
43. MacFarlane LA, Murphy PR. MicroRNA: biogenesis, function and role in cancer. Current Genomics 2010, 11:537-561.
44. Cassar O, Blondot ML, Mohanna S, Jouvion G, Bravo F, Maco V, Duprez R, Huerre M, Gotuzzo E, Gessain A. Human herpesvirus 8 genotype E in patients with Kaposi sarcoma, Peru. Emerg Infect Dis 2010, 16(9):1459-1462.
45. Kasolo FC, Spinks J, Bima H, Bates M, Gompels UA. Diverse genotypes of Kaposi's sarcoma associated herpesvirus (KSHV) identified in infant blood infections in African childhood-KS and HIV/AIDS endemic region. J Med Virol 2007, 79(10):1555-1561.
46. Ramos da Silva S, Ferraz da Silva AP, Bacchi MM, Bacchi CE, Elgui de Oliveira D. KSHV genotypes A and C are more frequent in Kaposi sarcoma lesions from Brazilian patients with and without HIV infection, respectively. Cancer Letters 2010, 301(1):85-94.
47. Dolan A, Addison C, Gatherer D, Davison AJ, McGeoch DJ. The genome of Epstein-Barr virus type 2 strain AG876. Virology 2006, 350(1):164-170.
48. Nicholas J, Zong JC, Alcendor DJ, Ciufo DM, Poole LJ, Sarisky RT, Chiou CJ, Zhang X, Wan X, Guo HG, Reitz MS, Hayward GS. Novel organizational features, captured cellular genes, and strain variability within the genome of KSHV/HHV8. J Natl Cancer Inst Monogr 1998, 23:79-88.
49. Dittmer D, Lagunoff M, Renne R, Staskus K, Haase A, Ganem D. A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus. J Virol 1998, 72(10):8309-8315.
50. Moore PS, Boshoff C, Weiss RA, Chang Y. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 1996, 274:1739-1744.
51. Parravicini C, Chandran B, Corbellino M, Berti E, Paulli M, Moore PS, Chang Y. Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases. Am J Path 2000, 156(3):743-749.
52. Cesarman E, Moore PS, Rao PH, Inghirami G, Knowles DM, Chang Y. In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood 1995, 86(7):2708-2714.
53. Renne R, Zhong W, Herndier B, McGrath M, Abbey N, Kedes D, Ganem D. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nature Med 1996, 2(3):342-346.
54. Menezes J, Leibold W, Klein G, Clements G. Establishment and characterization of an Epstein-Barr virus (EBV)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma. Biomedicine 1975, 22:276-284.
55. Chomczynski P, Sacchi N. The single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162(1):156-159.
56. Gaillard C, Strauss F. Ethanol precipitation of DNA with linear polyacrylamide as carrier. Nucleic Acids Res 1990, 18(2):378.
57. Agilent Technologies eArray. Group Folder: Sugden Lab; Array Name: "KSHV_and_EBV", Design ID #027774.., https://earray.chem.agilent.com/earray/
58. NCBI-Gene Expression Omnibus (GEO). , http://www.ncbi.nlm.nih.gov/geo/
59. Pacific Northwest National Laboratory (PNNL). Publication 1036., http://omics.pnl.gov/view/publication_1036.html
60. Vollrath AL, Smith AA, Craven M, Bradfield CA. EDGE(3): a web-based solution for management and analysis of Agilent two color microarray experiments. BMC Bioinformatics 2009, 10:280.
61. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004, 5(10):R80.
62. Smyth GK. Limma: linear models for microarray data. Bioinformatics and Computational Biology Solutions using R and Bioconductor 2005, 397-420. New York: Springer, Gentleman R, Carey V, Dudoit S, Irizarry R, Huber W.
63. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004, 3:Article3.
64. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. JR Statist Soc B 1995, 57(1):289-300.
65. Gerard GF, Fox DK, Nathan M, D'Alessio JM. Reverse Transcriptase. Mol Biotech 1997, 8:61-77.
66. Eng JK, McCormack AL, Yates JRI. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J Am Soc Mass Spectrom 1994, 5:976-989.
67. ExPaSy Proteomics Server: Human Protein Initiative. [http://expasy.org/sprot/hpi/hpi_ftp.html]; File: "uniprot_sprot_human.dat.gz" downloaded 4/20/2010, 20277 protein entries.
68. Aguirre AJ, Robertson ES. Characterization of intertypic recombinants of the Epstein-Barr virus from the body-cavity-based lymphomas cell lines BC-1 and BC-2. Virology 1999, 264:359-369.
69. Yakushko Y, Hackmann C, Günther T, Rückert J, Henke M, Koste L, Alkharsah K, Bohne J, Grundhoff A, Schulz TF, Henke-Gendo C. Kaposi's sarcoma-associated herpesvirus bacterial artificial chromosome contains a duplication of a long unique region fragment within the terminal repeat region. J Virol 2011, 85(9):4612-4617.
70. Kim S, Gupta N, Pevzner PA. Spectral probabilities and generating functions of tandem mass spectra: a strike against decoy databases. J Proteome Res 2008, 7(8):3354-3363.
71. Qian WJ, Liu T, Monroe ME, Strittmatter EF, Jacobs JM, Kangas LJ, Petritis K, Camp DG II, Smith RD. Probability-based evaluation of peptide and protein identifications from tandem mass spectrometry and SEQUEST analysis: the human proteome. J Proteome Res 2005, 4(1):53-62.